Genzyme Corporation http://www.alacrastore.com/company-snapshot/Genzyme_Corporation-2018845 27 Nov 2009 02:19:50 EST 2018845 Genzyme Corporation en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/ccbn/T2527547T2527547ccbn/T2527547norm18 Nov 2009 02:06:15 EST2527547Final Transcript of GENZ presentation, 18-Nov-09 10:30am ETGenzyme Corporation106.0000FinalGenzyme Corporation at Lazard Capital Healthcare Conference TranscriptGENZ10:30am ETTranscript...We are also in the process of utilizing existing fill/finish capacity in Waterford and exploring capacities with our contract manufacturer organization. The Waterford plant is state-of-the-art. It was recently completed. It's approved for ###-unit Cerezyme fill/finish, and we'll be moving that product to Waterford by the end of the year. And then, obviously, over the long term, we need to address the fill/finish capacity at Allston, and we plan to do that in a very thorough way. But we think we have a strategy to bridge us in a way which will allow us to deliver on the commitments that we have made to our patients and to you all to ship Cerezyme starting late this month with the anticipation that we will be able to supply all patients with full doses -- essentially supply what we were supplying before this interruption by the first quarter of next year. We also believe that we will be able to start new shipments of Fabrazyme in December as we had previously communicated. This very short... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2560466T2560466ccbn/T2560466norm18 Nov 2009 02:04:56 EST2560466Final Transcript of GENZ presentation, 17-Nov-09 12:00pm ETGenzyme Corporation106.0000FinalGenzyme/Isis Investor Event at American Heart Association Conference TranscriptGENZ12:00pm ETTranscript...John Butler Genzyme - SVP, President Cardiometabolic & Renal Frederick Raal University of Witwatersrand - Director of the Carbohydrate and Lipid Metabolism Research Unit William Cromwell Presbyterian Cardiovascular Institute - Chief of the Division of Atherosclerosis and Lipoprotein Disorders John Kastelein University of Amsterdam - Chair, Department of Vascular Medicine... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/newstex/BW-0001-39768017BW-0001-39768017newstex/BW-0001-39768017xmlNewstex Inc.2005Targeted Genetics CorporationNewstex Inc.newstex.comnewstexBW-0001-39768017Business Wire0001Business WireBW1Newstex Inc.Business Wire04000000040160000401601804016001040160470400200004002006070000000701400007014004070030000700300613000000130100001301000516 Nov 2009 05:22:18 EST1800000018004000180120001801800011/16/2009 Nov. ##, #### (Business Wire) -- Targeted Genetics Corporation (NASDAQ: TGEN) today announced its financial results for the third quarter ended September ##, ####. For the quarter ended September ##, ####, the Company reported net...GENZYME CORPTARGETED GENETICS CORPGENZTGENNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T2553610T2553610ccbn/T2553610norm16 Nov 2009 04:06:14 EST2553610Final Transcript of GENZ conference call or presentation, 16-Nov-09 12:00pm ETGenzyme Corporation106.0000FinalGenzyme Corporation Investor Conference Call to discuss Response Letter on Lumizyme Application TranscriptGENZ12:00pm ETTranscript...Patrick Flanigan Genzyme Corporation - Senior Director, IR Henri Termeer Genzyme Corporation - Chairman, President, CEO Alison Lawton Genzyme Corporation - SVP Global Market Access David Meeker Genzyme Corporation - EVP Therapeutics, Biosurgery and Corporate Operations Geoffrey McDonough Genzyme Corporation - SVP, GM LSD Therapeutics Pam Williamson Genzyme Corporation - SVP Global Regulatory Affairs and Corporate Quality Compliance Michael Wyzga Genzyme Corporation - EVP Finance, CFO... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/B2553610B2553610ccbn/B2553610norm16 Nov 2009 04:06:00 EST2553610Edited Brief of GENZ conference call or presentation, 16-Nov-09 12:00pm ETGenzyme Corporation106.0000EditedGenzyme Corporation Investor Conference Call to discuss Response Letter on Lumizyme Application SummaryGENZ12:00pm ETBrief...Patrick Flanigan Genzyme Corporation - Senior Director, IR Henri Termeer Genzyme Corporation - Chairman, President, CEO Alison Lawton Genzyme Corporation - SVP Global Market Access David Meeker Genzyme Corporation - EVP Therapeutics, Biosurgery and Corporate Operations Geoffrey McDonough Genzyme Corporation - SVP, GM LSD Therapeutics Pam Williamson Genzyme Corporation - SVP Global Regulatory Affairs and Corporate Quality Compliance Michael Wyzga Genzyme Corporation - EVP Finance, CFO... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/newstex/BW-0001-39440802BW-0001-39440802newstex/BW-0001-39440802xmlNewstex Inc.2005Zacks.comNewstex Inc.newstex.comnewstexBW-0001-39440802Business Wire0001Business WireBW1Newstex Inc.Business Wire040000000401600004016048040160010401601804 Nov 2009 05:20:06 EST1800000018008000180040001900000019001000190010211900104511/4/2009 Nov. #, #### (Business Wire) -- Zacks Equity Research highlights McDonald's (NYSE: MCD ) as the Bull of the Day and Genzyme (Nasdaq: GENZ ) the Bear of the Day. In addition, Zacks Equity Research provides analysis on Berkshire Hathaway...BERKSHIRE HATHAWAY INC.BURLINGTON NORTHERN SANTA FE CORPGENZYME CORPWARREN E BUFFETTBNIBRK AGENZNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/B2342633B2342633ccbn/B2342633norm21 Oct 2009 04:07:00 EST2342633Edited Brief of GENZ earnings conference call or presentation, 21-Oct-09 11:00am ETGenzyme Corporation54.0000EditedGenzyme Corporation Q3 2009 Earnings Conference Call SummaryGENZ11:00am ETBrief...Patrick Flanigan Genzyme Corporation - Senior Director, IR Henri Termeer Genzyme Corporation - Chairman, CEO Michael Wyzga Genzyme Corporation - CFO David Meeker Genzyme Corporation - EVP Geoff McDonough Genzyme Corporation - SVP, GM, LSD Therapeutics John Butler Genzyme Corporation - SVP, President, Cardiometabolic & Renal Alison Lawton Genzyme Corporation - SVP, Global Market Access Mark Enyedy Genzyme Corporation - SVP, President, Oncology & Multiple Sclerosis... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2342633T2342633ccbn/T2342633norm21 Oct 2009 01:07:00 EST2342633Final Transcript of GENZ earnings conference call or presentation, 21-Oct-09 11:00am ETGenzyme Corporation54.0000FinalGenzyme Corporation Q3 2009 Earnings Conference Call TranscriptGENZ11:00am ETTranscript...Patrick Flanigan Genzyme Corporation - Senior Director, IR Henri Termeer Genzyme Corporation - Chairman, CEO Michael Wyzga Genzyme Corporation - CFO David Meeker Genzyme Corporation - EVP Geoff McDonough Genzyme Corporation - SVP, GM, LSD Therapeutics John Butler Genzyme Corporation - SVP, President, Cardiometabolic & Renal Alison Lawton Genzyme Corporation - SVP, Global Market Access Mark Enyedy Genzyme Corporation - SVP, President, Oncology & Multiple Sclerosis... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/newstex/BW-0001-39022385BW-0001-39022385newstex/BW-0001-39022385xmlNewstex Inc.2005Genzyme Corp.Newstex Inc.newstex.comnewstexBW-0001-39022385Business Wire0001Business WireBW1Newstex Inc.Business Wire07000000070130000700500007001000040000000400200004002006040160000401601804016001040160030401600904007000040070030701400007014008070140120701400413000000130100001301000521 Oct 2009 10:22:53 EST18000000180200001801100018004000190000001900100019002000190020071900200419002018190020091900201310/21/2009 Oct. ##, #### (Business Wire) -- Genzyme Corp. (NASDAQ: GENZ) today reported that third-quarter revenue was $#.## billion, compared with $#.## billion in the same period a year ago. Results reflect the impact of the temporary interruption...GENZYME CORPHENRI A TERMEERGENZNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-38490902BW-0001-38490902newstex/BW-0001-38490902xmlNewstex Inc.2005Genzyme CorporationNewstex Inc.newstex.comnewstexBW-0001-38490902Business Wire0001Business WireBW1Newstex Inc.Business Wire170000001700200007000000070010000400000004017000040170020400600004006004040020000400200102 Oct 2009 10:20:31 EST1800000018005000190000001900100010/2/2009 Oct. #, #### (Business Wire) -- Genzyme Corporation (Nasdaq: GENZ) announced today that it was included on both the #### Dow Jones Sustainability World Index and North American Index. This marks the fifth consecutive year Genzyme has...GENZYME CORPHENRI A TERMEERGENZNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T2455501T2455501ccbn/T2455501norm23 Sep 2009 01:07:00 EST2455501Final Transcript of GENZ presentation, 23-Sep-09 9:30am ETGenzyme Corporation54.0000FinalGenzyme Corporation at UBS Global Life Sciences Conference TranscriptGENZ9:30am ETTranscript...Maged Shenouda - UBS - Analyst Good morning and thank you for joining us on the third day of the UBS global life sciences conference. I am Maged Shenouda, US large-cap biotech analyst. It is my pleasure to introduce Genzyme, a well diversified company with a strong presence in the lysosomal storage disease area. Presenting from the company today is Henri Termeer, President and Chairman and Chief Executive Officer of Genzyme. This presentation will be a little different from the previous presentations. There will be no breakout session today. Henri will make opening comments and then he will go -- then a presentation and then we will go through a few questions we've prepared after the presentation. Again, there will be no breakout session. Henri? Henri Termeer - Genzyme Corporation - Chairman, President and CEO Thank you very much. It is great to be here. The no breakout relates to the no webcast of the breakout session, and I was told that we can't have a breakout session during our quiet... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/research/s-and-p-credit-research-Summary_Genzyme_Corp-747981747981spcred/747981normglobalstructured23 Sep 2009 10:40:00 EST175SummaryThe latest Summary from S&PUnited StatesBiotechnologyEurope, Middle East, AfricaUnited StatesGlobal IssuersStructured FinanceSummaryUSA37291735201010 352010 3520 35Genzyme Corp.118603EUROMIDAFRUSAGENZABSConsumerCORPGLOBISSHealthSTRUCSUMMARYCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/ccbn/T2423791T2423791ccbn/T2423791norm16 Sep 2009 10:06:00 EST2423791Preliminary Transcript of GENZ presentation, 16-Sep-09 1:00pm UKTGenzyme Corporation54.0000PreliminaryGenzyme Corporation at Bank of America/Merrill Lynch Global Healthcare Conference TranscriptGENZ1:00pm UKTTranscript...Derik De Bruin Well, good morning. Welcome to the second day of the UBS Global Life Sciences Conference. I am Derik De Bruin, the senior US life sciences analyst. It is my pleasure to introduce this morning Life Technologies and presenting for the Company will be Greg Lucier, President and Chairman and CEO of the Company. Immediately following the presentation will be a breakout session in the Broadway level conference room. Greg? Greg Lucier Good morning, everybody. It is a pleasure to be here with you to talk about Life Technologies. Before we begin, let me just be clear that I will be sharing with you some forward-looking statements and as such, they are covered under the Safe Harbor Act. ... for going on seven years and the reality is, today, I couldn't even be more excited about where we are going with this Company. We have a great brand, we have incredible presence around the... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2400881T2400881ccbn/T2400881norm15 Sep 2009 11:06:00 EST2400881Final Transcript of GENZ presentation, 15-Sep-09 9:10am ETGenzyme Corporation54.0000FinalGenzyme Corporation at Morgan Stanley Global Healthcare Conference TranscriptGENZ9:10am ETTranscript...Emily Merchant Genzyme Corporation - IR John Butler Genzyme Corporation - SVP, President of Cardiometabolic & Renal C O N F E R E N C E C A L L P A R T I C I P A N T S... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/newstex/MW-0001-37827438MW-0001-37827438newstex/MW-0001-37827438xmlNewstex Inc.2005Copyright (c) 2009, Marketwire. All rights reserved. All the news releases provided by Market Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited.Targeted GeneticsSEATTLE, WANewstex Inc.newstex.comnewstexMW-0001-37827438Marketwire0001MarketwireMW1Newstex Inc.Marketwire040000000401900007000000070140000701400413000000130100001301000511000000110160001101600102000000020020000200200806000000060020000600200809 Sep 2009 07:21:53 EST180000001801800018020000190020079/9/2009 SEATTLE, WA, Sep. #, #### (Marketwire delivered by Newstex) -- SEATTLE, WA -- (Marketwire) -- ##/##/## -- Targeted Genetics Corporation (NASDAQ: TGEN) today announced the sale to Genzyme Corporation of certain assets, including manufacturing...GENZYME CORPTARGETED GENETICS CORPGENZTGENNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/B2186860B2186860ccbn/B2186860norm22 Jul 2009 01:06:00 EST2186860Edited Brief of GENZ earnings conference call or presentation, 22-Jul-09 11:00am ETGenzyme Corporation54.0000EditedGenzyme Corporation Q2 2009 Earnings Conference Call SummaryGENZ11:00am ETBrief...Patrick Flanigan Genzyme Corporation - Senior Dir of IR Henri Termeer Genzyme Corporation - Pres, Chairman, CEO David Meeker Genzyme Corporation - Pres, LSD Therapeutics Geoff McDonough Genzyme Corporation - SVP, GM, LSD Therapeutics CONFERENCE CALL PARTICIPANTS... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2186860T2186860ccbn/T2186860norm22 Jul 2009 01:06:00 EST2186860Final Transcript of GENZ earnings conference call or presentation, 22-Jul-09 11:00am ETGenzyme Corporation54.0000FinalGenzyme Corporation Q2 2009 Earnings Conference Call TranscriptGENZ11:00am ETTranscript...Patrick Flanigan Genzyme Corporation - Senior Dir of IR Henri Termeer Genzyme Corporation - Pres, Chairman, CEO David Meeker Genzyme Corporation - Pres, LSD Therapeutics Geoff McDonough Genzyme Corporation - SVP, GM, LSD Therapeutics C O N F E R E N C E C A L L P A R T I C I P A N T S... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/B2280217B2280217ccbn/B2280217norm16 Jun 2009 03:05:00 EST2280217Edited Brief of GENZ conference call or presentation, 16-Jun-09 12:00pm ETGenzyme Corporation54.0000EditedGenzyme Corporation Investor Conference Call SummaryGENZ12:00pm ETBrief...Patrick Flanigan Genzyme Corporation - Senior Director, IR Henri Termeer Genzyme Corporation - Chairman, President and CEO David Meeker Genzyme Corporation - EVP, Therapeutics, Biosurgery and Transplant Alison Lawton Genzyme Corporation - SVP, Global Market Access Geoff McDonough Genzyme Corporation - SVP Rich Moscicki Genzyme Corporation - SVP, Biomedical and Regulatory Affairs, and Chief Medical Officer Mark Bamforth Genzyme Corporation - SVP, Corporate Operations and Pharmaceuticals Mike Wyzga Genzyme Corporation - EVP, Finance and CFO CONFERENCE CALL PARTICIPANTS... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T2280217T2280217ccbn/T2280217norm16 Jun 2009 03:05:00 EST2280217Final Transcript of GENZ conference call or presentation, 16-Jun-09 12:00pm ETGenzyme Corporation54.0000FinalGenzyme Corporation Investor Conference Call TranscriptGENZ12:00pm ETTranscript...Patrick Flanigan Genzyme Corporation - Senior Director, IR Henri Termeer Genzyme Corporation - Chairman, President and CEO David Meeker Genzyme Corporation - EVP, Therapeutics, Biosurgery and Transplant Alison Lawton Genzyme Corporation - SVP, Global Market Access Geoff McDonough Genzyme Corporation - SVP Rich Moscicki Genzyme Corporation - SVP, Biomedical and Regulatory Affairs, and Chief Medical Officer Mark Bamforth Genzyme Corporation - SVP, Corporate Operations and Pharmaceuticals Mike Wyzga Genzyme Corporation - EVP, Finance and CFO C O N F E R E N C E C A L L P A R T I C I P A N T S... Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/bir/321587321587bir/321587norm17Genzyme Corp.Integrated Genetics Inc.Allegro Biologics Div.FOCAL Inc.Sangstat Medical Corp.Ilex Oncology Inc.United States27 May 2009 06:19:00 ESTGenzyme Corporation was founded in Delaware in 1981, and reincorporated as a Massachusetts corporation in 1991. It is a global biotechnology company organized into four reporting segments that each develop, manufacture and distribute specialized products:NASDAQ325414K2836I325412339112621511384128348071GENZGenzyme Corporation was founded in Delaware in 1981, and reincorporated as a Massachusetts corporation in 1991. It is a global biotechnology company organized into four reporting segments that each develop, manufacture and distribute specialized products:Company Profiles & FinancialsGale Company Profiles